Kymera Therapeutics, Inc. (KYMR)

Healthcare · Biotechnology · NASDAQ

Kymera Therapeutics, Inc. (KYMR) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $10.04B and a free-cash-flow yield of -2.3%. Over the most recent reported fiscal year, revenue declined 16.7%.

Market cap	$10.04B
Trailing P/E	—
FCF yield	-2.3%
Revenue growth (YoY)	-16.7%
EPS growth (YoY)	—
FCF/share growth (YoY)	—
Exchange	NASDAQ
Sector	Healthcare
Industry	Biotechnology

Explore live KYMR data on Nama Insights →